Report - CAR-T 治療產品之非臨床試驗審查考量 - CDE · 被開發成功之作用的標的為CD19，用於血液相關腫瘤(NHL、ALL、CLL 等)治療。常見 的腫瘤相關抗原許多已有CAR-T

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form